-
Product Insights
NewLikelihood of Approval Analysis for Retinitis Pigmentosa (Retinitis)
Overview How likely is it that the drugs in Retinitis Pigmentosa (Retinitis) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Retinitis Pigmentosa (Retinitis) Overview Retinitis pigmentosa refers to a group of...
-
Product Insights
NewLikelihood of Approval Analysis for Macular Degeneration
Overview How likely is it that the drugs in Macular Degeneration will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Macular Degeneration Overview Macular degeneration is primarily an age-related retinal condition. There...
-
Product Insights
NewLikelihood of Approval Analysis for Uveitis
Overview How likely is it that the drugs in Uveitis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Uveitis Overview Uveitis is swelling and irritation of the uvea, the middle layer...
-
Product Insights
Green Vision-Brasov Solar PV Park – 1
Green Vision-Brasov Solar PV Park - 1 is a solar PV project located in Brasov, Romania. The project is owned by Hareon Solar Technology Co Ltd; Jiangsu Sunshine Group Co Ltd and is developed by Conecon GmbH; Green Vision Seven SRL; Hareon Solar Technology Co Ltd. The project is currently partially active. Empower your strategies with our Green Vision-Brasov Solar PV Park - 1 report and make more profitable business decisions. Note: This is an on-demand report that will be...
-
Product Insights
NewLikelihood of Approval Analysis for Retinal Vascular Occlusion
Overview How likely is it that the drugs in Retinal Vascular Occlusion will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Retinal Vascular Occlusion Overview Retinal vascular occlusion is a condition that...
-
Product Insights
NewLikelihood of Approval Analysis for Multiple Sclerosis
Overview How likely is it that the drugs in Multiple Sclerosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Multiple Sclerosis Overview Multiple sclerosis (MS) is an autoimmune disease in which...
-
Product Insights
NewLikelihood of Approval Analysis for Metastatic Uveal Melanoma
Overview How likely is it that the drugs in Metastatic Uveal Melanoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Metastatic Uveal Melanoma Overview Metastatic uveal melanoma is a rare and...
-
Sector Analysis
NewIntraocular Lens (IOL) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Intraocular Lens (IOL) Market Report Overview The intraocular lens (IOL) market was valued at $4.48 billion in 2023 and the market will grow at more than 2% during 2023-2033. The rising prevalence of cataracts and refractive error coupled with the increasing population around the globe has compelled governments to start initiatives toward lowering the number of patients suffering from partial or complete blindness. This, in turn, will lead to an increase in the number of eye surgeries and the use...
-
Product Insights
NewLikelihood of Approval Analysis for Posterior Uveitis
Overview How likely is it that the drugs in Posterior Uveitis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Posterior Uveitis Overview Posterior uveitis refers to intraocular inflammation in the vitreous,...
-
Sector Analysis
NewOphthalmic Viscoelastic Devices (OVD) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Ophthalmic Viscoelastic Devices (OVD) Market Report Overview The ophthalmic viscoelastic devices (OVD) market size was $1.2 billion in 2023. The market will grow at a CAGR of more than 2% during 2023-2033. Ophthalmic viscoelastic devices, also known as OVDs, are devices used during intraocular surgery, especially anterior segment surgery. These are the viscoelastic materials used to maintain space in the eye during surgery. Typically, OVDs are pre-packaged in a syringe and are applied using a small tube. Essential properties of...